Introduction {#sec1-1}
============

*Vibrio parahaemolyticus* is a Gram-negative, halophilic bacterium that naturally inhabits the marine, estuarine, and coastal environments. *V. parahaemolyticus* is commonly responsible for acute gastroenteritis illness and to lesser frequency wound infections and septicemia in humans \[[@ref1]\]. Infections due to this bacterium are associated with the consumption of contaminated seafood \[[@ref2],[@ref3]\] and exposure of open wounds to seawater \[[@ref4]\]. Recently, *V. parahaemolyticus* has also been reported to be the causative agent of acute hepatopancreatic necrosis syndrome in penaeid shrimp taking a heavy toll on the shrimp aquaculture industry \[[@ref5]\]. *V. parahaemolyticus* pathogenicity has been attributed to several virulence determinants including the well-known thermostable direct hemolysin (TDH) and TDH-related hemolysin encoded by the *tdh* and *trh* genes, respectively \[[@ref6]\]. A recent study has demonstrated a significant association between the virulence factor *tdh* and the presence of clustered regularly interspaced short palindromic repeats (CRISPR)/cas in *V. parahaemolyticus* \[[@ref7]\].

The CRISPR-cas (CRISPR-associated proteins) system is a prokaryotic adaptive immune system against genomic invaders such as viruses and plasmids \[[@ref8],[@ref9]\]. Due to its importance and widespread applications, it has been a subject for comprehensive research recently \[[@ref10]\]. The CRISPR-cas system consists of short (\~25-40 bp) direct DNA repeats separated by spacer sequences and associated variable *cas* genes \[[@ref8]\]. The Cas proteins are a diverse group of proteins which are believed to function as nucleases, helicases, and RNA-binding proteins \[[@ref11]\]. Defense against foreign genetic elements is achieved in three stages: Adaptation, expression, and interference. The adaptation stage involves the integration of foreign DNA fragments into the bacterial genome at the CRISPR loci. The second stage is characterized by the expression of *cas* genes and the transcription of the CRISPR loci to generate a crRNA precursor (pre-crRNA) which is later processed into mature-crRNAs. During interference, the target nucleic acid is recognized and destroyed by the combined action of crRNA and Cas proteins \[[@ref11],[@ref12]\]. The CRISPR-cas system has been identified in several bacterial and archaeal genomes \[[@ref13],[@ref14]\] and broadly classified into five major types (I-V) and 16 subtypes (IA-F, I-U, IIA-C, IIIA-D, IV, and V), based on the organization of the CRISPR locus, *cas* gene assembly, and their interference mechanisms \[[@ref15]\]. Studies show that different types of CRISPR-cas systems have evolved distinct mechanisms for a mature crRNA generation \[[@ref16]\]. In type I-III systems, the mature-crRNA is generated specifically by the Cas protein Cas6 \[[@ref17]\]. The Cas6 is a member of the RNA-binding protein superfamily called repeat-associated mysterious proteins (RAMPs) \[[@ref18]\] which play a central role in generating guide RNAs for invader defense in prokaryotes \[[@ref19]\]. The Cas6 proteins are also reported to be highly divergent and are thought to have coevolved with the highly variable CRISPR RNA repeat sequences \[[@ref13]\].

In our previous study, based on computational analysis of existing *V. parahaemolyticus* *cas6* gene sequences in database, we have shown the existence of four subtypes for *cas6*, designated *cas6*-a, *cas6*-b, *cas6*-c, and *cas6*-d \[[@ref20]\]. In this study, we designed novel primers for the polymerase chain reaction (PCR) detection and characterization of *cas6* gene variants in *V. parahaemolyticus*. We report the variant types harbored for the Cas6 endoribonuclease in *V. parahaemolyticus*. Few of the *cas6* sequences were sequenced to look for further variations within the variant types.

Materials and Methods {#sec1-2}
=====================

Ethical approval {#sec2-1}
----------------

Ethical approval was not applicable, as this study does not involve any human or animal studies.

Bacterial strains {#sec2-2}
-----------------

*V. parahaemolyticus* stock cultures (n=38) maintained in Tryptic soy broth with 30% glycerol at −80°C at the Department of Fisheries Microbiology, College of Fisheries, Mangalore, were used in the experiments. The cultures were revived by growing them overnight in 5 ml of Luria-Bertani (LB) broth (HiMedia Laboratories Private Limited, Mumbai, India) at 37°C in a shaker incubator. A loopful of the culture was streaked onto thiosulfate-citrate-bile salts-sucrose agar (HiMedia Laboratories Pvt. Limited, Mumbai, India) to check for the purity of the cultures. *V. parahaemolyticus* strains used in this study are listed in [Table-1](#T1){ref-type="table"}.

###### 

*Vibrio parahaemolyticus* isolates used in this study.

  S.No   Isolate   Isolation region   Isolation source       Presence of *cas6*/subtype
  ------ --------- ------------------ ---------------------- ----------------------------
  1      VP 1      Karwar             Shrimp                 +/d
  2      VPh 2     Karwar             Shrimp                 −
  3      VPh 3     Karwar             Shrimp farm sediment   +/d
  4      VP 15     Sasthan            Shrimp farm water      +/a
  5      VPh 4     Karwar             Shrimp farm water      −
  6      VP 5      Karwar             Shrimp farm sediment   +/d
  7      VPh 6     Karwar             Shrimp farm water      −
  8      VPh 8     Kundapur           Shrimp                 −
  9      VPh 9     Kundapur           Shrimp farm water      −
  10     VP 4      Mulki              Clam                   −
  11     VPh 10    Kundapur           Shrimp farm water      −
  12     VPh 11    Ankola             Shrimp                 −
  13     VPh 7     Kundapur           Shrimp                 −
  14     VPh 12    Ankola             Shrimp                 −
  15     VPh 13    Ankola             Fish                   −
  16     VP 6      Mulki              Oyster                 +/a
  17     MR 32     Sasthan            clams                  +/a
  18     MR 34     Sasthan            clams                  −
  19     125       Gangolli           Shrimp farm water      −
  20     IIWVp     Katpadi            Shrimp farm water      −
  21     VPh 1     Sasthan            Oysters                −
  22     VP 3      Sasthan            Oyster                 −
  23     VP 9      Sasthan            Oyster                 +/a
  24     VP 10     Sasthan            Clam                   +/a
  25     VP 11     Sasthan            Oyster                 −
  26     VP 7      Mulki              Clam                   +/a
  27     VP 8      Sasthan            Oyster                 +/a
  28     VP 14     Mulki              Oyster                 +/a
  29     VP 18     Mulki              Fish                   −
  30     VP 19     Sasthan            Oyster                 −
  31     VP 20     Mulki              Oyster                 −
  32     VP 21     Mulki              Clam                   −
  33     VP 22     Sasthan            Clam                   −
  34     VP 23     Mulki              Oyster                 +/a
  35     VP 25     Mulki              Clam                   +/a
  36     VP 27     Sasthan            Clam                   +/a
  37     VP 17     Sasthan            Clam                   +/a
  38     VPh 5     Mulki              Oyster                 −

Primer design and PCR validation of *cas6* gene variants {#sec2-3}
--------------------------------------------------------

The primers used in this study were designed based on respective *cas6* gene sequences available in GenBank database, using the Primer 3.0 software \[[@ref21]\]. The primer sequences are listed in [Table-2](#T2){ref-type="table"}.

###### 

Primers designed in this study for the detection of *cas6* gene variants.

  Gene                  Primer                  Sequence (5'- 3')         Annealing temperature   Expected product size
  --------------------- ----------------------- ------------------------- ----------------------- -----------------------
  *cas6*-a (internal)   *cas6*-a F              CCAAGAAACGGTGGGACGTA      60°C                    245 bp
  *cas6*-a R            CGCGTTCTAAAGCTCTTCGC                                                      
  *cas6*-a (full)       IF-a-F                  GAACCATCACATTTTTACCTGAA   50°C                    597 bp
  IF-a-R                CAATGGAACAACCTGCAATG                                                      
  *cas6*-b              IF-b-F                  TTATTGGCGGGTCGCTGTAT      60°C                    506 bp
  IF-b-R                TTCGTTGCGAGTCCGTAACT                                                      
  *cas6*-c              IF-c-F                  GAAGCATTAATCGGGCACTG      51°C                    500 bp
  IF-c-R                GTCCATAACTTGAGAATGCCC                                                     
  *cas6*-d              IF-d-F                  TGGACTACTACCAAGAAATTAC    46°C                    600 bp
                        IF-d-R                  TAAAATTGTGGGACAGTC                                

PCR and sequencing of *cas6* gene {#sec2-4}
---------------------------------

Crude lysate of each strain was prepared by first growing them on LB broth at 37°C. 450 µl of ×1 TE buffer was added to 50 µl of the culture and subjected to heating at 94°C for 1 min in the hot dry bath followed by snap cooling in ice. PCR for the identification of *cas6* gene type was carried out using primers designed to target the *cas6* gene types. The PCR was carried out in a 30 µl reaction mixture consisting of 3 µl of ×10 PCR buffer (Genei^™^, Merck Bioscience, Bengaluru), 50 µM each of the four deoxynucleotide triphosphates, 10 pmol of each primer, and 1.0 U of *Taq* DNA polymerase (Genei^™^, Merck Bioscience, Bengaluru). 2 µl of crude lysate was used as DNA template. The PCR assay was carried out in a Programmable Thermocycler (PTC 200, Bio-Rad, CA) with the program as follows: Initial denaturation at 94°C for 5 min, 30 cycles of 94°C for 1 min, annealing temperature as listed in [Table-2](#T2){ref-type="table"} for 1 min, 72°C for 1 min, and a final extension at 72°C for 10 min. The PCR products were resolved in 1.5% agarose gel containing 0.5 mg/ml ethidium bromide, and the size of amplicons was determined by comparison with a 100 bp DNA ladder (Genei^™^, Merck Bioscience, Bengaluru). The bands were visualized using a Gel documentation system (Bio-Rad, USA). The generated PCR products were sequenced (Bioserve Biotechnologies Limited, Hyderabad). The *V. parahaemolyticus* strains VP49 (which harbors the cas6-a genotype) and AQ4037 (reference strain) were used as positive and negative controls, respectively.

*In silico* analysis {#sec2-5}
--------------------

The *V. parahaemolyticus* cas6 sequences were downloaded from the National Centre for Biotechnology Information (<https://www.ncbi.nlm.nih.gov/>) database. The sequences obtained from our study were aligned with these sequences using the program MultAlin\[[@ref22]\] and grouped based on similarity. The phylogenetic tree was generated using MEGA ver.5.0 \[[@ref23]\].

Results {#sec1-3}
=======

PCR for *cas6* gene {#sec2-6}
-------------------

In this study, the primers designed were used to evaluate and detect the *cas6* gene subtypes in seafood and environmental isolates of *V. parahaemolyticus*. For initial identification of the type *cas6*-a, in *V. parahaemolyticus*, the PCR primers cas6-aF and cas6-aR ([Table-2](#T2){ref-type="table"}) were used, targeting an internal fragment of the gene. Among the 38 isolates studied, 12 (31.58%) amplified the expected product size of 245 bp ([Figure-1](#F1){ref-type="fig"}) indicating the presence of *cas6*-a subtype in these strains. Similarly, three strains (VP1, VP5, and VPh3) were found to be positive for the type *cas6*-d variant and amplified a product size of 600 bp ([Figure-2](#F2){ref-type="fig"}). However, *cas6*-b and *cas6*-c were not detectable in our strains. The remaining strains showed no amplification with any of the primers and hence considered negative for the presence of *cas6* gene. The PCR products of six isolates (Vp6, Vp8, Vp9, Vp10, Vp14, and Vp17) positive for the *cas6*-a gene variant were sequenced using the primers IF-a-F (forward) and IF-a-R (reverse) to generate a sequence of 597bp ([Table-2](#T2){ref-type="table"}). Two (Vp1 and Vp5) of the three strains positive for type *cas6*-d were also sequenced.

![Polymerase chain reaction amplification of *cas6*-a subtype in *Vibrio parahaemolyticus*. N: Negative control; P: Positive control; M: 100 bp DNA marker; Lane 1-38: Environmental isolates of *V. parahaemolyticus*.](Vetworld-12-689-g001){#F1}

![Polymerase chain reaction (PCR) amplification of *cas6*-d subtype in *Vibrio parahaemolyticus*. Only samples positive for PCR shown. Lanes 1-15: Environmental isolates of *V. parahaemolyticus*. M: 100bp DNA marker.](Vetworld-12-689-g002){#F2}

*In silico* analysis of *V. parahaemolyticus cas6* sequences {#sec2-7}
------------------------------------------------------------

The phylogenetic tree generated based on Cas6 amino acid sequences was seen to subgroup into four major clusters (*cas6*-a-*cas6*-d, [Figure-3](#F3){ref-type="fig"}). Pairwise alignment of representative Cas6 protein sequences from the different groups showed the sequences to be diverse with a homology of 21-47% between sequences. It was also seen that there exist residue differences within sequences within a given cluster (Figures-[4a](#F4){ref-type="fig"} and [b](#F4){ref-type="fig"}). Sequence analysis of the protein identified in this study showed proteins with accession IDs AUD40493, AUD40494, AUD40495, AUD40496, AUD 40497, and AUD40498 to be grouped along with the cas6-a and AUD40499 and AUD40500 grouped with Cas6-d proteins.

![Phylogenetic tree of representative *cas6* protein sequences. Represents Cas6-a (AUD40493, AUD40494, AUD40495, AUD40496, AUD40497, and AUD40498) and Cas6-d (AUD40499 and AUD40500) subtypes identified in this study.](Vetworld-12-689-g003){#F3}

![(a) Alignment of Cas6-a protein sequences of *Vibrio parahaemolyticus*. Vp6, Vp8-10, Vp14, and Vp17 represent environmental strains from this study. Amino acid variations among sequences are shown. (b) Alignment of Cas6-d protein sequences of *V. parahaemolyticus*. Vp1 and Vp5 represent environmental strains from this study. Amino acid variations among sequences are shown.](Vetworld-12-689-g004){#F4}

Discussion {#sec1-4}
==========

*V. parahaemolyticus* is known to harbor the type IF CRISPR-cas system \[[@ref7]\]. *V. parahaemolyticus* subtype IF is associated with CRISPR-associated genes *cas1*, *cas3*, *cas8*, *cas5*, *cas7*, and *cas6*. However, a search for *cas* genes in this study showed that the majority (\>90%) of *V. parahaemolyticus* strains contain a minimalistic type IF system containing core genes *cas5*, *cas7*, and *cas6*. Among these, the peripheral Cas6 domain belongs to the RAMP family of RNases functioning as an endonuclease that interacts with CRISPR RNAs to generate crRNAs \[[@ref24],[@ref25]\]. Cas5 and Cas7 also belong to the RAMP superfamily and are implicated in interference and stabilization stages of crRNA generation \[[@ref26]\]. Bioinformatics-based analysis of the *V. parahaemolyticus cas6* sequence showed the existence of four different sequence subtypes (*cas6*-a-*cas6*-d), with a majority of strains analyzed seen associated with *cas6*-a subtype \[[@ref20]\]. The subtypes cas6-b and cas6-c were not detected in the strains studied which probably is due to the under-representation of environmental strains taken for analysis. A BLAST analysis for the *V. parahaemolyticus* *cas6*-b, *cas6*-c, and *cas6*-d subtypes showed homologous *cas6* to be present in *Vibrio anguillarum*, *Vibrio cholerae*, *Vibrio fluvialis*, *Vibrio vulnificus*, and several other *Vibrio* spp. There is much evidence that horizontal transfer of CRISPR and *cas* genes can occasionally occur between different strains, species, and even distant genera \[[@ref26]\], which probably explains the diversity seen for *cas6* gene in *V. parahaemolyticus*. Cas6 belonging to the CRISPR-cas type IF system functions as an endonuclease that cleaves CRISPR RNAs to generate pre-crRNA \[[@ref16]\]. Recent studies have shown that *cas6* (subtype IF) in *Pseudomonas* spp. recognizes its pre-crRNA substrate with high affinity, recognition of which is mediated by sequence and structure-specific interactions \[[@ref17],[@ref27]\]. *V. parahaemolyticus* also contains the type IF system, but studies on its Cas6-mediated cleavage and the process to generate a pre-crRNA are lacking. Therefore, based on the diversity observed for *cas6* gene sequences in this study, we probably presume that, in *V. parahaemolyticus*, the Cas6 endonuclease could be functioning in more ways than one in recognizing the primary transcript and in bringing about cleavage. Further, in this study, an alignment of subtypes of *cas6*-a and *cas6*-d sequences revealed substitutions in several amino acid loci in the Cas6 protein ([Figure-4a](#F4){ref-type="fig"} and [b](#F4){ref-type="fig"}). This could be of significance, as studies show that mutations in any of the catalytic residues reduce the endonuclease activity of Cas6 resulting in non-cleaved pre-crRNA \[[@ref27],[@ref28]\]. Whether these substitutions have any influence on the endonuclease activity, bringing about altered antiviral immunity, therefore, remains to be seen.

The gene coding for *cas6* endonuclease plays a critical role in the CRISPR cas-based adaptive immunity \[[@ref29]\]. Studying the prevalence of the genes encoding these systems in seafood and/or environmental isolates of *V. parahaemolyticus* is expected to open new avenues in understanding the dynamics of the CRISPR-based immunity in this pathogen. Our study has elucidated the diversity of *cas6* gene in CRISPR-cas operon harboring *V. parahaemolyticus*. Thus, the PCR primers designed in this study could help in identifying and distinguishing the presence of *cas6* endoribonuclease variants in this pathogenic bacterium.

In the CRISPR-mediated immunity system, the *cas* genes are functionally paired with CRISPR repeats \[[@ref30]\]. Thus, the absence of *cas6* gene in several of our environmental isolates indicates the presence of a sub-population of *V. parahaemolyticus* that probably lacks the CRISPR-cas system. To ascertain this, our future work would focus on studying CRISPR loci and finding an association with their presence/absence to *cas* genes in *V. parahaemolyticus*. Representative *cas6* genes pertaining to types *cas6*-a and *cas6*-d have been sequenced and deposited in GenBank having accession numbers MG417090 (strain Vp8); MG417091 (StrainVp9); MG417092 (StrainVp10); MG417093 (StrainVp14); MG417094 (StrainVp6); MG417095 (StrainVp17); MG417096 (StrainVp1); and MG417097 (StrainVp5).

Conclusion {#sec1-5}
==========

In prokaryotes harboring the CRISPR-cas type I-F system, the Cas6-associated protein functions as an endoribonuclease bringing about cleavage of the CRISPR RNAs and generation of pre-crRNA \[[@ref16]\]. In *V. parahemolyticus*, a previous study with *cas6* showed the gene sequences to be diverse and broadly classified into four genotypes \[[@ref20]\]. The primers designed in this study could be used in the identification of the *cas6* genotypes in *V. parahaemolyticus*. Further, our studies with seafood and environmental samples show the cas6-a variant to be most prevalent. Altered Cas6 could probably impact endoribonuclease activity. Thus, the proper identification of *cas6* genotypes in strains of *V. parahaemolyticus* is needed, which could contribute in understanding further the impact of such altered genotypes on the CRISPR--Cas immune system of this pathogenic bacterium.
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